Pharming (PHAR) Operating Income (2020 - 2026)
Pharming's Operating Income was $29.90 in Q3 2026, up 89.2% from $15.80 a year earlier.
Powered by 
Analysis
Pharming (PHAR) Operating Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pharming's Operating Income was -$8.5 million through Sep 30, 2026; for FY2025, it was $25.84 million.
- Operating Income shows a five-year compound annual growth rate of -19.5% (FY2020 to FY2025).
- In earlier years, Operating Income was -$15.3 million in FY2024, -$5.39 million in FY2023, $28.4 million in FY2022 (+65.1%) and $17.2 million in FY2021 (-77.4%).
- The Q3 2026 figure marks the highest quarterly Operating Income since Q2 2025.
- Compared with a year earlier, Operating Income was higher in 1 of the last four quarters, with an average decline of 29.6%.
- The best year-over-year quarter for Operating Income over five years was Q3 2024 (growth of 114.9%); the worst was Q3 2025 (a decline of 100.0%).
- Per Business Quant data, PHAR's Operating Income in the three quarters before Q3 2026 was -$3.6 million (Q2 2026), -$4.9 million (Q1 2026) and $6.20 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Pharming | 927.62 Mn | 229.29 Mn | 102.20 | 29.90 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.90 |
| Jun 30, 2026 | -3.60 Mn |
| Mar 31, 2026 | -4.91 Mn |
| Dec 31, 2025 | 6.20 |
| Sep 30, 2025 | 15.80 |
| Jun 30, 2025 | 3.81 Mn |
| Mar 31, 2025 | -7.04 Mn |
| Dec 31, 2024 | 6.70 |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | -19.43 Mn |
| Mar 31, 2024 | -16.31 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | -13.66 Mn |
| Dec 31, 2022 | -10.20 Mn |
| Sep 30, 2022 | 7.80 Mn |
| Jun 30, 2022 | 17.80 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 15.30 Mn |
API Access
Pharming Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();